Assessing immune infiltration and the tumor microenvironment for the diagnosis and prognosis of sarcoma

Table 1 Estimate scores, Immune scores, Stromal scores, and clinical parameters of sarcoma samples

Characteristic	N	Estimate score (range)	Immune score (range)	Stromal score (range)
Age
< 61.5	135	−2977.42 to 5336.40	−1722.08 to 3499.29	−1336.63 to 2476.22
≥ 61.5	128	−2142.73 to 5178.61	−1135.92 to 3382.39	−2142.73 to 5178.61
Gender
Female	144	−2886.10 to 5336.41	−1722.09 to 3499.29	−1336.63 to 2032.58
Male	119	−2977.43 to 4985.82	−1646.75 to 3382.38	−1330.67 to 2476.22
Disease type
Fibromatous	40	−504.94 to 5336.41	−962.99 to 3499.29	153.81 to 2157.00
Lipomatous	60	−1889.11 to 5187.61	−1110.77 to 3382.39	−778.34 to 2476.22
Myomatous	106	−2114.77 to 4221.40	−1520.77 to 2998.72	−727.47 to 1727.86
Nerve sheath	10	−490.23 to 3520.43	−733.46 to 2271.22	−122.82 to 1249.22
Soft tissue	37	−274.38 to 4985.82	−496.70 to 3348.72	106.11 to 1731.42
Synovial-like	10	−2977.43 to 726.05	−1722.08 to −174.09	−1336.63 to 900.13
Tumor total necrosis (%)
0%	71	−2886.10 to 5336.41	−1722.08 to 3499.29	−1336.63 to 2230.57
< 10%	38	−1645.38 to 4600.14	−1067.28 to 3027.08	−628.27 to 1985.01
≥ 10, < 50%	62	−2977.43 to 4510.53	−1646.76 to 3140.17	−1330.67 to 1793.80
> 50%	12	−2114.77 to 3725.37	−1520.77 to 2293.27	−727.46 to 1707.18
Unknown	80	−1889.11 to 5178.61	−1110.77 to 3199.34	−778.34 to 2476.22
Disease recurrence
Yes	29	−2647.50 to 4104.67	−1722.08 to 2386.97	−925.41 to 1985.01
No	146	−2977.43 to 5336.41	−1646.76 to 3499.29	−1336.63 to 2230.57
Unknown	88	−1889.11 to 5178.61	−1110.77 to 3199.35	−778.34 to 2476.22

ISSN: 1475-2867